✦ LIBER ✦

The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia

✍ Scribed by Hitchcock-Bryan, Suzanne ;Gelber, Richard ;Cassady, J. Robert ;Sallan, Stephen E.

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 508 KB
Volume: 14
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950140405

No coin nor oath required. For personal study only.

✦ Synopsis

Early intensive therapy might be critical in improving failure-free survival for children with acute lymphoblastic leukemia. Between 1973 and 1977, 107 children received vincristine and prednisone (VP) induction and 30 received the same two agents plus an anthracycline (VPA). Ninety-nine of the VP-treated group and all 30 of the VPA-treated patients achieved complete remission.

At a median observation time of 10 years, 59 of 137 children remain in continuous complete remission. Failure-free survival was 37% for the VP group and 63% for the VPA group (p = 0.02). Failure-free survival for boys who received VP was 28%, compared with 68% for boys who received VPA (p = 0,007). All 11 extramedullary relapses and all seven relapses occurring beyond 3.8 years from diagnosis (three testicular and four bone marrow) were observed among the VP group. We conclude that use of an anthracycline during remission induction therapy influenced failure-free survival and that early results of successful antileukemic therapy in children must be confirmed by follow-up progress reports.

📜 SIMILAR VOLUMES

Low-dose daunorubicin in induction treat

Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group

✍ Rammeloo, L.A.J. ;Postma, A. ;Sobotka-Plojhar, M.A. ;Bink-Boelkens, M.Th.E. ;Ber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 3 views

Impact of the timing of triple intrathec

Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: A pediatric oncology group study

✍ Hvizdala, Eva ;Berry, D. H. ;Chen, Timothy ;Dyment, Paul G. ;Kim, Tae H. ;Steube 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisone, cytosine arabinoside) starting on day 1 of treatment were added to systemic induction therapy in a regimen (Arm 3) that was compared to three other regimens (Arms 1, 2, and 4) in which central nervous system (CN

Prophylactic cranial irradiation of acut

Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: Outcomes of late effects on pituitary function and growth in long-term survivors

✍ Masaharu Hata; Ichiro Ogino; Noriko Aida; Kimihiko Saito; Motoko Omura; Hisato K 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB

It is well known that prophylactic cranial irradiation is highly effective in preventing central nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL). Nevertheless, there have been very few reports on the late effects, especially pituitary function and growth, in long-term survivors wh

Survival after relapse in childhood acut

Survival after relapse in childhood acute lymphoblastic leukemia : Impact of site and time to first relapse-the Children's Cancer Group experience

✍ Paul S. Gaynon; Roger P. Qu; Richard J. Chappell; Michael L. N. Willoughby; Davi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 3 views

other childhood cancers. The survival of patients who relapse despite improved therapy continues to be of interest.

Long-term survival of patients with acut

Long-term survival of patients with acute myeloid leukemia : A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia

✍ Clara D. Bloomfield; Cynthia Shuma; Linda Regal; Preben P. Philip; Dieter K. Hos 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 2 views

## Background: In 1982, the fourth international workshop on chromosomes in leukemia reviewed data prospectively collected on 716 patients with acute myeloid leukemia (aml) diagnosed between 1980 and 1982. the present study examined the extended follow-up on these patients. ## Methods: The analys